Related Experiment Video
Updated: Mar 19, 2026
12:55
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
22.1K
[Immunotherapy for brain tumors: obstacles and perspectives].
Revue Medicale Suisse
|June 11, 2016
Summary
Immunotherapy offers new hope for glioblastoma, a highly aggressive brain tumor. Recent advances show promise for improving patient outcomes beyond standard treatments.
Area of Science:
- Neuro-oncology
- Immunotherapy
- Cancer research
Context:
- Glioblastomas are aggressive brain tumors with poor prognosis.
- Standard treatments (surgery, radiation, chemotherapy) have limited efficacy.
- Immunotherapy is an emerging strategy with growing interest.
Purpose:
- To review current clinical applications of immunotherapy in neuro-oncology.
- To discuss the impact of recent immunotherapy advancements on brain tumors.
- To provide insights into future perspectives for brain tumor immunotherapy.
Summary:
- Glioblastomas remain challenging due to their aggressive nature and poor prognosis despite conventional therapies.
- Recent breakthroughs in immunotherapy, including immune checkpoint inhibitors and adoptive cell therapy, have transformed cancer treatment.
- This review explores the evolving role and potential of immunotherapy in treating brain tumors.
Impact:
- Immunotherapy advancements are shifting the paradigm in cancer treatment, offering new hope for patients with brain tumors.
- Understanding the clinical applications and future directions of immunotherapy is crucial for advancing neuro-oncology.
- This work highlights the potential of immunotherapy to improve outcomes for glioblastoma patients.
More Related Videos
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
8.5K
06:15Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
28.0K
Related Concept Videos
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
01:30Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
02:56Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
02:56Treatment Resistent Cancers
1.5K
1.5K
02:49Cancer Therapies
10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K